Alysa Walker

569 total citations
10 papers, 452 citations indexed

About

Alysa Walker is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Alysa Walker has authored 10 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Oncology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Alysa Walker's work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (7 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Alysa Walker is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (7 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Alysa Walker collaborates with scholars based in United States. Alysa Walker's co-authors include Christine Hoffer, Dale Whittington, Evan D. Kharasch, Pamela Sheffels, E D Kharasch, Seongjun Park, Nina Isoherranen, Kenneth E. Thummel and Leslie J. Dickmann and has published in prestigious journals such as Anesthesiology, Clinical Pharmacology & Therapeutics and Drug and Alcohol Dependence.

In The Last Decade

Alysa Walker

10 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alysa Walker United States 9 257 192 161 78 74 10 452
Srikanth C. Nallani United States 11 279 1.1× 241 1.3× 189 1.2× 302 3.9× 133 1.8× 17 877
Kerry Powell Golay Switzerland 8 153 0.6× 119 0.6× 76 0.5× 38 0.5× 71 1.0× 10 347
Matthew J. Zaya United States 10 342 1.3× 216 1.1× 173 1.1× 39 0.5× 23 0.3× 15 613
Irma H. Benedek United States 10 135 0.5× 88 0.5× 85 0.5× 75 1.0× 132 1.8× 20 509
D. A. Flockhart United States 9 283 1.1× 92 0.5× 132 0.8× 17 0.2× 24 0.3× 20 554
Rosario Calvo Spain 12 93 0.4× 128 0.7× 100 0.6× 25 0.3× 18 0.2× 30 470
S. G. Shin South Korea 7 146 0.6× 94 0.5× 98 0.6× 26 0.3× 28 0.4× 7 344
Bianca D. van Groen Netherlands 11 149 0.6× 240 1.3× 133 0.8× 27 0.3× 14 0.2× 18 411
Farzaneh Salem United Kingdom 9 119 0.5× 196 1.0× 46 0.3× 29 0.4× 23 0.3× 21 377
Iouri Bachmakov Germany 8 98 0.4× 152 0.8× 252 1.6× 22 0.3× 47 0.6× 11 414

Countries citing papers authored by Alysa Walker

Since Specialization
Citations

This map shows the geographic impact of Alysa Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alysa Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alysa Walker more than expected).

Fields of papers citing papers by Alysa Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alysa Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alysa Walker. The network helps show where Alysa Walker may publish in the future.

Co-authorship network of co-authors of Alysa Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Alysa Walker. A scholar is included among the top collaborators of Alysa Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alysa Walker. Alysa Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kharasch, Evan D., et al.. (2012). Lack of Indinavir Effects on Methadone Disposition Despite Inhibition of Hepatic and Intestinal Cytochrome P4503A (CYP3A). Anesthesiology. 116(2). 432–447. 30 indexed citations
2.
Walker, Alysa, Leslie J. Dickmann, & Nina Isoherranen. (2010). Pregnancy Decreases Rat CYP1A2 Activity and Expression. Drug Metabolism and Disposition. 39(1). 4–7. 5 indexed citations
3.
Kharasch, Evan D., et al.. (2009). Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity. Drug and Alcohol Dependence. 101(3). 158–168. 56 indexed citations
4.
Kharasch, Evan D., et al.. (2009). Methadone Pharmacokinetics Are Independent of Cytochrome P4503A (CYP3A) Activity and Gastrointestinal Drug Transport. Anesthesiology. 110(3). 660–672. 65 indexed citations
5.
Kharasch, E D, et al.. (2008). Mechanism of Ritonavir Changes in Methadone Pharmacokinetics and Pharmacodynamics: I. Evidence Against CYP3A Mediation of Methadone Clearance. Clinical Pharmacology & Therapeutics. 84(4). 497–505. 65 indexed citations
6.
Kharasch, E D, et al.. (2008). Mechanism of Ritonavir Changes in Methadone Pharmacokinetics and Pharmacodynamics: II. Ritonavir Effects on CYP3A and P-Glycoprotein Activities. Clinical Pharmacology & Therapeutics. 84(4). 506–512. 76 indexed citations
7.
Kharasch, Evan D., Alysa Walker, Nina Isoherranen, et al.. (2007). Influence of CYP3A5 Genotype on the Pharmacokinetics and Pharmacodynamics of the Cytochrome P4503A Probes Alfentanil and Midazolam. Clinical Pharmacology & Therapeutics. 82(4). 410–426. 77 indexed citations
8.
Kharasch, Evan D., Alysa Walker, Christine Hoffer, & Pamela Sheffels. (2005). Sensitivity of Intravenous and Oral Alfentanil and Pupillary Miosis as Minimally Invasive and Noninvasive Probes for Hepatic and First‐Pass CYP3A Activity. The Journal of Clinical Pharmacology. 45(10). 1187–1197. 26 indexed citations
9.
Kharasch, Evan D., Alysa Walker, Christine Hoffer, & Pamela Sheffels. (2004). Evaluation of First‐Pass Cytochrome P4503A (CYP3A) and P‐Glycoprotein Activities Using Alfentanil and Fexofenadine in Combination. The Journal of Clinical Pharmacology. 45(1). 79–88. 26 indexed citations
10.
Kharasch, Evan D., Christine Hoffer, Alysa Walker, & Pamela Sheffels. (2003). Disposition and miotic effects of oral alfentanil: A potential noninvasive probe for first‐pass cytochrome P4503A activity. Clinical Pharmacology & Therapeutics. 73(3). 199–208. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Srikanth C. Nallani Breakdown of academic impact, for papers by Kerry Powell Golay Breakdown of academic impact, for papers by Matthew J. Zaya Breakdown of academic impact, for papers by Irma H. Benedek Breakdown of academic impact, for papers by D. A. Flockhart Breakdown of academic impact, for papers by Rosario Calvo Breakdown of academic impact, for papers by S. G. Shin Breakdown of academic impact, for papers by Bianca D. van Groen Breakdown of academic impact, for papers by Farzaneh Salem Breakdown of academic impact, for papers by Iouri Bachmakov
Rankless by CCL
2026